Who has invested in Surface Pharmaceuticals?

Flying L Partners are named among the investors backing Surface Pharmaceuticals.

Surface Pharmaceuticals Funding: $25M Raised, Series A

Surface Pharmaceuticals funding overview

Surface Pharmaceuticals is based in Pleasanton. Surface Pharmaceuticals has raised $25M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2021. The round record for Surface Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Flying L Partners.

Surface Pharmaceuticals at a glance

Total raised: $25M
Latest round: Series A
Latest round date: July 2021
Headquarters: Pleasanton
Notable investors: Flying L Partners

Frequently asked about Surface Pharmaceuticals funding

How much has Surface Pharmaceuticals raised?: Surface Pharmaceuticals has raised $25M in total disclosed funding across the rounds on record.
Who has invested in Surface Pharmaceuticals?: Flying L Partners are named among the investors backing Surface Pharmaceuticals.
What was the latest Surface Pharmaceuticals funding round?: The most recent disclosed round is a Series A, announced in July 2021.
Where is Surface Pharmaceuticals based?: Surface Pharmaceuticals is based in Pleasanton.
When did Surface Pharmaceuticals last raise?: The last disclosed Surface Pharmaceuticals round closed in July 2021 at Series A.

Totals shown for Surface Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Pleasanton and the investors behind them below.

Surface Pharmaceuticals Funding: $25M Raised, Series A

Surface Pharmaceuticals funding overview

Surface Pharmaceuticals at a glance

Frequently asked about Surface Pharmaceuticals funding

Companies related to Surface Pharmaceuticals (18)

Browse related funding lists (3)